| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1640266/0001959173-26-002755.txt","as_of":"2026-04-03T11:12:58.166696+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1640266/0001959173-26-002755.txt","company":"Voyager Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1640266/0001959173-26-002755.txt","article_chars":1990,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_b7f2ded3ca8351e3","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1640266/0001959173-26-002755.txt","content_type":"text/plain","enriched_at":"2026-04-03T12:43:04.178982+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1640266/0001959173-26-002755.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1640266/0001959173-26-002755.txt","source_event_id":"evt_21ed6354e50e","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"56ae2c6f0808bca9","kind":"sec_filing","published_at":"20260402","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.9,"dates_mentioned":["2026-04-02","2026-04-01","2026-02-10","2026-02-18","2026-02-24"],"entities":[{"asset_class":"equity","name":"Voyager Therapeutics, Inc.","relevance":"issuer","symbol":"VYGR","type":"company"}],"event_type":"listing","information_gaps":["No details on the total number of shares sold or the exact amount of tax obligations covered."],"key_facts":["Form 144 filed on April 2, 2026.","Alfred W. Sandrock Jr. is the reporting owner.","Sale includes amounts to cover tax obligations from vested equity awards."],"numeric_claims":[],"primary_claim":"Voyager Therapeutics, Inc. filed Form 144 on April 2, 2026.","relevance_score":0.5,"sentiment":"neutral","source_quality":"medium","summary":"Voyager Therapeutics, Inc. filed Form 144 on April 2, 2026, indicating a sale of common stock by an officer, Alfred W. Sandrock Jr., to cover tax obligations from vested equity awards.","topics":["SEC Filing","Stock Sale","Executive Compensation"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Voyager Therapeutics, Inc. \u00b7 Filed 20260402","ticker":"VYGR","tickers":["VYGR"],"title":"VYGR filed 144","url":"https://www.sec.gov/Archives/edgar/data/1640266/0001959173-26-002755.txt"}... |